| Product Code: ETC9937464 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Allergy Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Allergy Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Allergy Market - Industry Life Cycle |
3.4 United Kingdom (UK) Allergy Market - Porter's Five Forces |
3.5 United Kingdom (UK) Allergy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Allergy Market Revenues & Volume Share, By Allergan Type, 2021 & 2031F |
3.7 United Kingdom (UK) Allergy Market Revenues & Volume Share, By Disease Areas, 2021 & 2031F |
3.8 United Kingdom (UK) Allergy Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 United Kingdom (UK) Allergy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 United Kingdom (UK) Allergy Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 United Kingdom (UK) Allergy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Allergy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of allergies in the United Kingdom |
4.2.2 Growing awareness and diagnosis of allergies |
4.2.3 Technological advancements in allergy testing and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with allergy testing and treatment |
4.3.2 Limited reimbursement policies for allergy-related expenses |
4.3.3 Lack of standardized allergy management protocols |
5 United Kingdom (UK) Allergy Market Trends |
6 United Kingdom (UK) Allergy Market, By Types |
6.1 United Kingdom (UK) Allergy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Allergy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Allergy Market Revenues & Volume, By Antihistamines, 2021- 2031F |
6.1.4 United Kingdom (UK) Allergy Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.5 United Kingdom (UK) Allergy Market Revenues & Volume, By Decongestants, 2021- 2031F |
6.1.6 United Kingdom (UK) Allergy Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.1.7 United Kingdom (UK) Allergy Market Revenues & Volume, By Mast Cell Stabilizers, 2021- 2031F |
6.1.8 United Kingdom (UK) Allergy Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.2 United Kingdom (UK) Allergy Market, By Allergan Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Allergy Market Revenues & Volume, By Airborne Allergens, 2021- 2031F |
6.2.3 United Kingdom (UK) Allergy Market Revenues & Volume, By Food Allergens, 2021- 2031F |
6.2.4 United Kingdom (UK) Allergy Market Revenues & Volume, By Insect Stings/ Bites, 2021- 2031F |
6.2.5 United Kingdom (UK) Allergy Market Revenues & Volume, By Drug Allergens, 2021- 2031F |
6.2.6 United Kingdom (UK) Allergy Market Revenues & Volume, By Metal/ Chemical Allergens, 2021- 2031F |
6.2.7 United Kingdom (UK) Allergy Market Revenues & Volume, By Animal Saliva, 2021- 2031F |
6.3 United Kingdom (UK) Allergy Market, By Disease Areas |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Allergy Market Revenues & Volume, By Allergic Rhinitis, 2021- 2031F |
6.3.3 United Kingdom (UK) Allergy Market Revenues & Volume, By Atopic Dermatitis, 2021- 2031F |
6.3.4 United Kingdom (UK) Allergy Market Revenues & Volume, By Conjunctivitis, 2021- 2031F |
6.3.5 United Kingdom (UK) Allergy Market Revenues & Volume, By Urticaria, 2021- 2031F |
6.3.6 United Kingdom (UK) Allergy Market Revenues & Volume, By Asthma, 2021- 2031F |
6.3.7 United Kingdom (UK) Allergy Market Revenues & Volume, By Anaphylaxis, 2021- 2031F |
6.3.8 United Kingdom (UK) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.3.9 United Kingdom (UK) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Allergy Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Allergy Market Revenues & Volume, By Liquid, 2021- 2031F |
6.4.3 United Kingdom (UK) Allergy Market Revenues & Volume, By Solid, 2021- 2031F |
6.4.4 United Kingdom (UK) Allergy Market Revenues & Volume, By Semi-Solid, 2021- 2031F |
6.5 United Kingdom (UK) Allergy Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Allergy Market Revenues & Volume, By Nasal, 2021- 2031F |
6.5.3 United Kingdom (UK) Allergy Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.4 United Kingdom (UK) Allergy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.5 United Kingdom (UK) Allergy Market Revenues & Volume, By Topical, 2021- 2031F |
6.5.6 United Kingdom (UK) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Allergy Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Allergy Market Revenues & Volume, By Prescription, 2021- 2031F |
6.6.3 United Kingdom (UK) Allergy Market Revenues & Volume, By Over the Counter, 2021- 2031F |
6.7 United Kingdom (UK) Allergy Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 United Kingdom (UK) Allergy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 United Kingdom (UK) Allergy Market Revenues & Volume, By Homecare, 2021- 2031F |
6.7.4 United Kingdom (UK) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 United Kingdom (UK) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.8 United Kingdom (UK) Allergy Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 United Kingdom (UK) Allergy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.8.3 United Kingdom (UK) Allergy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.8.4 United Kingdom (UK) Allergy Market Revenues & Volume, By Competitive Lands, 2021- 2031F |
6.8.5 United Kingdom (UK) Allergy Market Revenues & Volume, By Competitive Lands, 2021- 2031F |
7 United Kingdom (UK) Allergy Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Allergy Market Export to Major Countries |
7.2 United Kingdom (UK) Allergy Market Imports from Major Countries |
8 United Kingdom (UK) Allergy Market Key Performance Indicators |
8.1 Percentage increase in allergy diagnosis rates |
8.2 Adoption rate of advanced allergy testing technologies |
8.3 Number of allergy clinics or specialists in the United Kingdom |
8.4 Patient satisfaction with allergy treatment options |
8.5 Rate of new allergy treatment approvals by regulatory authorities |
9 United Kingdom (UK) Allergy Market - Opportunity Assessment |
9.1 United Kingdom (UK) Allergy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Allergy Market Opportunity Assessment, By Allergan Type, 2021 & 2031F |
9.3 United Kingdom (UK) Allergy Market Opportunity Assessment, By Disease Areas, 2021 & 2031F |
9.4 United Kingdom (UK) Allergy Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 United Kingdom (UK) Allergy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 United Kingdom (UK) Allergy Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 United Kingdom (UK) Allergy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 United Kingdom (UK) Allergy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Allergy Market - Competitive Landscape |
10.1 United Kingdom (UK) Allergy Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Allergy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here